UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) December 9, 2004 Commission File Number 0-50218 EMPS RESEARCH CORPORATION ------------------------------------------------------ (Exact Name of Registrant as Specified in its Charter) NEVADA 87-0669131 ------------------------------- ------------------------------- (State or other jurisdiction of (I.R.S. Employer Identification incorporation or organization) Number) 875 Donner Way, Unit 705, Salt Lake City, Utah ---------------------------------------------- (Address of principal executive offices) 84108 ---------- (Zip Code) (801) 582-1881 ----------------------------------------------- (Registrant's Executive Office Telephone Number) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act 1 Item 7.01 Regulation FD On December 9, 2004, EMPS Research Corporation issued a press release announcing that it has agreed to acquire 100% of the outstanding capital stock of Condesa Pacific, S.A., in exchange for 35,000,000 common shares of EMPS Research Corporation. A copy of the press release is furnished as Exhibit 99.01 to this report and incorporated herein by this reference. Item 9.01 Exhibit and Financial Statements (a) Exhibits 99.1 Press Release of EMPS Research Corporation, dated December 9, 2004 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. EMPS RESEARCH CORPORATION Date: December 9, 2004 By: /s/ Dr. Terrence Chatwin --------------------------------- Dr. Terrence Chatwin, President 2